RB1 and breast cancer: In MDA- MB-231 breast cancer cells, EB treatment showed only moderate alterations in RB phosphorylation (Ser795, Ser807 and Ser811), indicating that G1-S phase progression was not affected by EB treatment (Figure 4B).